Benefits From and Barriers to Portable Detection of Gluten, Based on a Randomized Pilot Trial of Patients With Celiac Disease

Randi L Wolf; Peter H R Green; Anne R Lee; Norelle R Reilly; Patricia Zybert; Benjamin Lebwohl

doi:10.1016/j.cgh.2019.03.011

Benefits From and Barriers to Portable Detection of Gluten, Based on a Randomized Pilot Trial of Patients With Celiac Disease

Clin Gastroenterol Hepatol. 2019 Nov;17(12):2605-2607. doi: 10.1016/j.cgh.2019.03.011. Epub 2019 Mar 15.

Authors

Randi L Wolf¹, Peter H R Green², Anne R Lee², Norelle R Reilly², Patricia Zybert¹, Benjamin Lebwohl³

Affiliations

¹ Department of Health & Behavior Studies, Program in Nutrition, Teachers College, Columbia University, New York, New York.
² Department of Medicine, Celiac Disease Center, Columbia University Medical Center, New York, New York.
³ Department of Medicine, Celiac Disease Center, Columbia University Medical Center, New York, New York; Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, New York. Electronic address: [email protected].

Abstract

Research links diminished quality of life (QOL) to the challenges of a strict gluten-free diet (GFD), the only treatment for celiac disease (CD).^1-4 This pilot study assessed the acceptability and feasibility of a portable gluten sensor device (Nima) to promote GFD adherence and QOL.

Trial registration: ClinicalTrials.gov NCT03321214.

Publication types

Randomized Controlled Trial
Research Support, N.I.H., Extramural

MeSH terms

Adolescent
Adult
Anxiety / etiology
Celiac Disease / diet therapy
Diet, Gluten-Free
Female
Food Analysis / instrumentation*
Food Contamination / analysis
Glutens / analysis*
Humans
Male
Pilot Projects
Quality of Life

Substances

Glutens

Associated data

ClinicalTrials.gov/NCT03321214

Grants and funding

UL1 TR001873/TR/NCATS NIH HHS/United States